Abbott Laboratories (ABT) stock
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3049% above fair value
$108.52+1.27 (+1.18%)
Close on Nov 13, 2026Market cap $187.78BP/E 40.2Yield 2.21%
Abbott Laboratories profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Abbott Laboratories's profit margin for the twelve months ending Sep 30, 2026 was 9.7%. For fiscal 2025 it was 14.7%, against 31.9% the year before. The highest annual figure on record is 31.9% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.7% | −17.2 |
| FY2024 | Dec 31, 2024 | 31.9% | +17.7 |
| FY2023 | Dec 31, 2023 | 14.3% | −1.6 |
| FY2022 | Dec 31, 2022 | 15.9% | −0.5 |
| FY2021 | Dec 31, 2021 | 16.4% | +3.4 |
| FY2020 | Dec 31, 2020 | 13.0% | +1.4 |
| FY2019 | Dec 31, 2019 | 11.6% | +3.8 |
| FY2018 | Dec 31, 2018 | 7.7% | +6.0 |
| FY2017 | Dec 31, 2017 | 1.7% | −5.0 |
| FY2016 | Dec 31, 2016 | 6.7% | −15.0 |
| FY2015 | Dec 31, 2015 | 21.7% | +10.4 |
| FY2014 | Dec 31, 2014 | 11.3% | −1.8 |
| FY2013 | Dec 31, 2013 | 13.1% | −18.2 |
| FY2012 | Dec 31, 2012 | 31.3% | +9.2 |
| FY2011 | Dec 31, 2011 | 22.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 7.1% | −7.4 |
| Q2 FY2026 | Jun 30, 2026 | 7.4% | −8.6 |
| Q1 FY2026 | Mar 31, 2026 | 9.6% | −3.1 |
| Q4 FY2025 | Dec 31, 2025 | 15.5% | −68.6 |
| Q3 FY2025 | Sep 30, 2025 | 14.5% | −1.0 |
| Q2 FY2025 | Jun 30, 2025 | 16.0% | +3.4 |
| Q1 FY2025 | Mar 31, 2025 | 12.8% | +0.5 |
| Q4 FY2024 | Dec 31, 2024 | 84.1% | +68.5 |
| Q3 FY2024 | Sep 30, 2024 | 15.5% | +1.3 |
| Q2 FY2024 | Jun 30, 2024 | 12.5% | −1.2 |
| Q1 FY2024 | Mar 31, 2024 | 12.3% | −1.2 |
| Q4 FY2023 | Dec 31, 2023 | 15.6% | +5.3 |
| Q3 FY2023 | Sep 30, 2023 | 14.2% | +0.4 |
| Q2 FY2023 | Jun 30, 2023 | 13.8% | −4.1 |
| Q1 FY2023 | Mar 31, 2023 | 13.5% | −7.0 |
| Q4 FY2022 | Dec 31, 2022 | 10.2% | −7.1 |
| Q3 FY2022 | Sep 30, 2022 | 13.8% | −5.4 |
| Q2 FY2022 | Jun 30, 2022 | 17.9% | +6.3 |
| Q1 FY2022 | Mar 31, 2022 | 20.6% | +3.4 |
| Q4 FY2021 | Dec 31, 2021 | 17.3% | −2.9 |
| Q3 FY2021 | Sep 30, 2021 | 19.2% | +5.3 |
| Q2 FY2021 | Jun 30, 2021 | 11.6% | +4.3 |
| Q1 FY2021 | Mar 31, 2021 | 17.1% | +9.8 |
| Q4 FY2020 | Dec 31, 2020 | 20.2% | +7.6 |
| Q3 FY2020 | Sep 30, 2020 | 13.9% | +2.0 |
| Q2 FY2020 | Jun 30, 2020 | 7.3% | −5.3 |
| Q1 FY2020 | Mar 31, 2020 | 7.3% | −1.6 |
| Q4 FY2019 | Dec 31, 2019 | 12.6% | +4.2 |
| Q3 FY2019 | Sep 30, 2019 | 11.9% | +4.5 |
| Q2 FY2019 | Jun 30, 2019 | 12.6% | +3.2 |
| Q1 FY2019 | Mar 31, 2019 | 8.9% | +3.3 |
| Q4 FY2018 | Dec 31, 2018 | 8.4% | +19.3 |
| Q3 FY2018 | Sep 30, 2018 | 7.4% | −1.5 |
| Q2 FY2018 | Jun 30, 2018 | 9.4% | +5.2 |
| Q1 FY2018 | Mar 31, 2018 | 5.7% | −1.0 |
| Q4 FY2017 | Dec 31, 2017 | -10.9% | −25.9 |
| Q3 FY2017 | Sep 30, 2017 | 8.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 4.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 6.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 15.0% | – |
See a number that looks wrong?